ArticleWorld journal of emergency surgery : WJES2026
Percutaneous vs. surgical management in acute cholecystitis: addressing selection bias in meta-analyses.
Article in World journal of emergency surgery : WJES, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Percutaneous versus surgical treatment of acute cholecystitis.World journal of emergency surgery : WJES · 2026Article
- Gaps and insights toward evidence-based management for acute cholecystitis patients at high surgical risk.Endoscopic ultrasoundReview
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This commentary addresses the recent research titled "Comparing percutaneous treatment and cholecystectomy outcomes in acute cholecystitis patients: a systematic review and meta-analysis" published in the World Journal of Emergency Surgery. The review confirms that cholecystectomy (CC), particularly laparoscopic, is associated with lower mortality and readmission rates compared to percutaneous cholecystostomy (PC). However, this commentary emphasizes that the interpretation of these findings must account for inherent selection bias: in clinical practice, PC is typically reserved for higher-risk patients who are unfit for immediate surgery. Thus, the observed outcome differences partially reflect disparities in baseline risk rather than therapeutic efficacy alone. The review's true value lies in reinforcing early CC as the standard of care for suitable patients and clarifying the role of PC as a "bridge therapy" to stabilize patients for subsequent definitive surgery. Future research should focus on optimizing risk stratification and timing of delayed CC after PC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.